Taficita-EM (Descovy)
Previous
Next

Taficita-EM (Descovy)

$53.61
No tax
Full stock
Supply

Introducing Taficita-EM (Descovy) at GetInPrEP: Your Premier Choice for Modern HIV Prevention. Taficita-EM, a cutting-edge PrEP medication, combines the latest in antiretroviral technology with tenofovir alafenamide and emtricitabine, offering superior protection against HIV with a more favorable safety profile than older generations. Ideal for those seeking effective HIV prophylaxis, Taficita-EM minimizes the risk of bone density and kidney-related side effects, setting a new standard in PrEP care.

For more information about Taficita-EM (Descovy), consult your doctor or pharmacist. You can also find information on reputable health websites and in the literature provided by the medication's manufacturer.

Brand

Data sheet

Expire date
10/26
Trademark
Descovy
Use
PrEP
Active principle
Emtricitabine / Alafenamide
Supply Length
30 Tablets
Dosage
1 tablet daily
Presentation
Film-Coated Tablets
Comments (1)
Grade
No customer reviews for the moment.